
Zuvicella 0.5ml Vaccine
Salt Composition: Inactivated Hepatitis A Vaccine(Adsorbed)
Expiry Date: 01/2028
Inclusive of all taxes
1

Zuvicella 0.5ml Vaccine
1
Inactivated Hepatitis A Vaccine(Adsorbed)
Salt Composition
Inactivated Hepatitis A Vaccine(Adsorbed)
Storage
2–8°C
Expiry Date
01/2028
Marketer
Zuventus Healthcare Ltd
Brand
Zuvicella

Havrix 0.5ml Vaccine
1 Vial in a Pack
Inactivated Hepatitis A Vaccine(Adsorbed)
Salt Composition
Inactivated Hepatitis A Vaccine(Adsorbed)
Storage
2–8°C
Expiry Date
01/2028
Marketer
Glaxo SmithKline Pharmaceuticals Ltd
Brand
Havrix
5966.png&w=1920&q=75)
MAGIC DEALS
Enquire
Apply Promo Code
Available CouponsZuvicella 0.5ml Vaccine
Inclusive of all taxes
In Stock
Authorized
Global Reach
Verified Logistics
The price displayed is inclusive of applicable taxes. Any additional fee (such as shipping fee, handling and/or platform fee etc.) will be clearly disclosed before you complete your purchase.
About The Product
Chikenpox
Overview
Zuvicella 0.5ml Vaccine contains Varicella Vaccine (live) attenuated (NA) as an active ingredient. It is indicated for active immunization for prevention of chickenpox in individuals 12 months of age & older.
This Vaccine should be given under the skin or into the muscle of the upper arm in two doses.
Zuvicella 0.5ml Vaccine Uses and Indications
Prevention of Chickenpox
Zuvicella 0.5ml Vaccine Side Effects
Side effects are unwanted symptoms that can occur from any medical treatment. Like other medications, the Zevicella 0.5ml Vaccine can also have adverse effects on the body, most of which resolve without the need for medical attention.
Some common side effects include:
Vaccine site reactions (pain, swelling, redness)
Fever
Seek medical attention in case of any unusual or severe side effects immediately
Zuvicella 0.5ml Vaccine Dosage and How To Take It
Zevicella 0.5ml Vaccine should be given by an experienced nurse or doctor. Please do not self-administer. It is given to children between 12 months to 12 years of age.
Also the second dose should be given after a minimum gap of 3 months. For adolescents & adults as well, it is given in two doses a minimum of 4 weeks apart.
How Zuvicella 0.5ml Vaccine Works
Zevicella 0.5ml Vaccine contains Varicella Vaccine (live) attenuated (NA) as an active ingredient. This vaccine helps to develop immunity by initiating a mild infection also this type of infection does not cause illness.
Mild infection caused by vaccine stimulate the body's immune system to produce antibodies to protect against any future infections. It can be given from children between 12 months to 12 years of age and to adolescents and adults as well. Vaccination is the best way to prevent chickenpox.
Safety Advice for Zuvicella 0.5ml Vaccine
Do not take Zevicella 0.5ml Vaccine without consulting the doctor in case of pregnancy, as it is an unsafe to take it during this period.
Zevicella 0.5ml Vaccine is safe to use while breastfeeding, if prescribed by the doctor. No dosage adjustment is necessary for this tablet as limited data is available that shows significant risk.
Zevicella 0.5ml Vaccine is safe for use in liver disease if prescribed by the doctor. No dosage adjustment is necessary for this Tablet.
FAQs About Zuvicella 0.5ml Vaccine
Zevicella 0.5ml Vaccine is indicated for active immunization for prevention of chickenpox in individuals 12 months of age & older.
References
Wang, W., Pan, D., Fu, W., Ye, X., Han, J., Yang, L., ... & Xia, N. (2022). Development of a skin-and neuro-attenuated live vaccine for varicella. Nature communications , 13 (1), 824.
Gershon, A. A. (2001). Live-attenuated varicella vaccine. Infectious disease clinics of North America , 15 (1), 65-81.
Gershon, A. A., Gershon, M. D., & Shapiro, E. D. (2021). Live attenuated varicella vaccine: prevention of varicella and of zoster. The Journal of Infectious Diseases , 224 (Supplement_4), S387-S397.
Levine, M. J., Ellison, M. C., Zerbe, G. O., Barber, D., Chan, C., Stinson, D., ... & Hayward, A. R. (2000). Comparison of a live attenuated and an inactivated varicella vaccine to boost the varicella-specific immune response in seropositive people 55 years of age and older. Vaccine , 18 (25), 2915-2920.
Arvin, A. M., & Gershon, A. A. (1996). Live attenuated varicella vaccine. Annual review of microbiology , 50 (1), 59-100.
Mo, Z. J., Huang, S. J., Qiu, L. X., Li, C. G., Yu, X. J., Li, M. Q., ... & Xia, N. S. (2023). Safety and immunogenicity of a skin-and neuro-attenuated live vaccine for varicella: a randomized, double-blind, controlled, dose-escalation and age de-escalation phase 1 clinical trial. The Lancet Regional Health–Western Pacific , 34 .
Medical Disclaimer
Accurate, reviewed information to support informed healthcare decisions
Magicine's primary objective is to ensure that its customers receive accurate, genuine, and trustworthy information reviewed by medical experts.
The content on this website has been produced solely for informational purposes. This is not intended to take the place of medical advice and care provided by a licensed professional, though.
This information may not include all potential side effects, warnings, and details about specific lab tests, medications, and medical conditions. Please ask your doctor any questions you may have about any drug or disease.
Our goal is not to replace or substitute for the doctor-patient relationship, but to uphold and strengthen it.
.jpeg%3FupdatedAt%3D1763121181831&w=128&q=75)